Global Measles Attenuated Live Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Measles Attenuated Live Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Measles Attenuated Live Vaccine players cover Merck, Pfizer, Serum Institute of India, GSK, Sanofi-Pasteur, Novartis, Bavarian Nordic, Medimmune and Changchun Keygen Biological Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Measles Attenuated Live Vaccine Industry Forecast” looks at past sales and reviews total world Measles Attenuated Live Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Measles Attenuated Live Vaccine sales for 2023 through 2029. With Measles Attenuated Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles Attenuated Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Measles Attenuated Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles Attenuated Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Measles Attenuated Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles Attenuated Live Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles Attenuated Live Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles Attenuated Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Measles Attenuated Live Vaccine market?
What factors are driving Measles Attenuated Live Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Measles Attenuated Live Vaccine market opportunities vary by end market size?
How does Measles Attenuated Live Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Measles Attenuated Live Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Measles Attenuated Live Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Measles Attenuated Live Vaccine players cover Merck, Pfizer, Serum Institute of India, GSK, Sanofi-Pasteur, Novartis, Bavarian Nordic, Medimmune and Changchun Keygen Biological Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Measles Attenuated Live Vaccine Industry Forecast” looks at past sales and reviews total world Measles Attenuated Live Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Measles Attenuated Live Vaccine sales for 2023 through 2029. With Measles Attenuated Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles Attenuated Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Measles Attenuated Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles Attenuated Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Measles Attenuated Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles Attenuated Live Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles Attenuated Live Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles Attenuated Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Powder
- Liquid
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Pfizer
- Serum Institute of India
- GSK
- Sanofi-Pasteur
- Novartis
- Bavarian Nordic
- Medimmune
- Changchun Keygen Biological Products
- Shanghai Institute of Biological Products
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
What is the 10-year outlook for the global Measles Attenuated Live Vaccine market?
What factors are driving Measles Attenuated Live Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Measles Attenuated Live Vaccine market opportunities vary by end market size?
How does Measles Attenuated Live Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Measles Attenuated Live Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Measles Attenuated Live Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Measles Attenuated Live Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Measles Attenuated Live Vaccine Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.3 Measles Attenuated Live Vaccine Sales by Type
2.3.1 Global Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Measles Attenuated Live Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Measles Attenuated Live Vaccine Sale Price by Type (2018-2023)
2.4 Measles Attenuated Live Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Measles Attenuated Live Vaccine Sales by Application
2.5.1 Global Measles Attenuated Live Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Measles Attenuated Live Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Measles Attenuated Live Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MEASLES ATTENUATED LIVE VACCINE BY COMPANY
3.1 Global Measles Attenuated Live Vaccine Breakdown Data by Company
3.1.1 Global Measles Attenuated Live Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Measles Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Measles Attenuated Live Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Measles Attenuated Live Vaccine Revenue by Company (2018-2023)
3.2.2 Global Measles Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Measles Attenuated Live Vaccine Sale Price by Company
3.4 Key Manufacturers Measles Attenuated Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Measles Attenuated Live Vaccine Product Location Distribution
3.4.2 Players Measles Attenuated Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MEASLES ATTENUATED LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Measles Attenuated Live Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Measles Attenuated Live Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Measles Attenuated Live Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Measles Attenuated Live Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Measles Attenuated Live Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Measles Attenuated Live Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Measles Attenuated Live Vaccine Sales Growth
4.4 APAC Measles Attenuated Live Vaccine Sales Growth
4.5 Europe Measles Attenuated Live Vaccine Sales Growth
4.6 Middle East & Africa Measles Attenuated Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Measles Attenuated Live Vaccine Sales by Country
5.1.1 Americas Measles Attenuated Live Vaccine Sales by Country (2018-2023)
5.1.2 Americas Measles Attenuated Live Vaccine Revenue by Country (2018-2023)
5.2 Americas Measles Attenuated Live Vaccine Sales by Type
5.3 Americas Measles Attenuated Live Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Measles Attenuated Live Vaccine Sales by Region
6.1.1 APAC Measles Attenuated Live Vaccine Sales by Region (2018-2023)
6.1.2 APAC Measles Attenuated Live Vaccine Revenue by Region (2018-2023)
6.2 APAC Measles Attenuated Live Vaccine Sales by Type
6.3 APAC Measles Attenuated Live Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Measles Attenuated Live Vaccine by Country
7.1.1 Europe Measles Attenuated Live Vaccine Sales by Country (2018-2023)
7.1.2 Europe Measles Attenuated Live Vaccine Revenue by Country (2018-2023)
7.2 Europe Measles Attenuated Live Vaccine Sales by Type
7.3 Europe Measles Attenuated Live Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Measles Attenuated Live Vaccine by Country
8.1.1 Middle East & Africa Measles Attenuated Live Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Measles Attenuated Live Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Measles Attenuated Live Vaccine Sales by Type
8.3 Middle East & Africa Measles Attenuated Live Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine
10.3 Manufacturing Process Analysis of Measles Attenuated Live Vaccine
10.4 Industry Chain Structure of Measles Attenuated Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Measles Attenuated Live Vaccine Distributors
11.3 Measles Attenuated Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR MEASLES ATTENUATED LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Measles Attenuated Live Vaccine Market Size Forecast by Region
12.1.1 Global Measles Attenuated Live Vaccine Forecast by Region (2024-2029)
12.1.2 Global Measles Attenuated Live Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Measles Attenuated Live Vaccine Forecast by Type
12.7 Global Measles Attenuated Live Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.1.3 Merck Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.2.3 Pfizer Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.4.3 GSK Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi-Pasteur
13.5.1 Sanofi-Pasteur Company Information
13.5.2 Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.5.3 Sanofi-Pasteur Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi-Pasteur Main Business Overview
13.5.5 Sanofi-Pasteur Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.6.3 Novartis Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Bavarian Nordic
13.7.1 Bavarian Nordic Company Information
13.7.2 Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.7.3 Bavarian Nordic Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bavarian Nordic Main Business Overview
13.7.5 Bavarian Nordic Latest Developments
13.8 Medimmune
13.8.1 Medimmune Company Information
13.8.2 Medimmune Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.8.3 Medimmune Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Medimmune Main Business Overview
13.8.5 Medimmune Latest Developments
13.9 Changchun Keygen Biological Products
13.9.1 Changchun Keygen Biological Products Company Information
13.9.2 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.9.3 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changchun Keygen Biological Products Main Business Overview
13.9.5 Changchun Keygen Biological Products Latest Developments
13.10 Shanghai Institute of Biological Products
13.10.1 Shanghai Institute of Biological Products Company Information
13.10.2 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.10.3 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai Institute of Biological Products Main Business Overview
13.10.5 Shanghai Institute of Biological Products Latest Developments
13.11 Wuhan Institute of Biological Products
13.11.1 Wuhan Institute of Biological Products Company Information
13.11.2 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.11.3 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Wuhan Institute of Biological Products Main Business Overview
13.11.5 Wuhan Institute of Biological Products Latest Developments
13.12 Lanzhou Institute of Biological Products
13.12.1 Lanzhou Institute of Biological Products Company Information
13.12.2 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.12.3 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lanzhou Institute of Biological Products Main Business Overview
13.12.5 Lanzhou Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Measles Attenuated Live Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Measles Attenuated Live Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Measles Attenuated Live Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Measles Attenuated Live Vaccine Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.3 Measles Attenuated Live Vaccine Sales by Type
2.3.1 Global Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Measles Attenuated Live Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Measles Attenuated Live Vaccine Sale Price by Type (2018-2023)
2.4 Measles Attenuated Live Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Measles Attenuated Live Vaccine Sales by Application
2.5.1 Global Measles Attenuated Live Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Measles Attenuated Live Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Measles Attenuated Live Vaccine Sale Price by Application (2018-2023)
3 GLOBAL MEASLES ATTENUATED LIVE VACCINE BY COMPANY
3.1 Global Measles Attenuated Live Vaccine Breakdown Data by Company
3.1.1 Global Measles Attenuated Live Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Measles Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Measles Attenuated Live Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Measles Attenuated Live Vaccine Revenue by Company (2018-2023)
3.2.2 Global Measles Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Measles Attenuated Live Vaccine Sale Price by Company
3.4 Key Manufacturers Measles Attenuated Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Measles Attenuated Live Vaccine Product Location Distribution
3.4.2 Players Measles Attenuated Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MEASLES ATTENUATED LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Measles Attenuated Live Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Measles Attenuated Live Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Measles Attenuated Live Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Measles Attenuated Live Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Measles Attenuated Live Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Measles Attenuated Live Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Measles Attenuated Live Vaccine Sales Growth
4.4 APAC Measles Attenuated Live Vaccine Sales Growth
4.5 Europe Measles Attenuated Live Vaccine Sales Growth
4.6 Middle East & Africa Measles Attenuated Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Measles Attenuated Live Vaccine Sales by Country
5.1.1 Americas Measles Attenuated Live Vaccine Sales by Country (2018-2023)
5.1.2 Americas Measles Attenuated Live Vaccine Revenue by Country (2018-2023)
5.2 Americas Measles Attenuated Live Vaccine Sales by Type
5.3 Americas Measles Attenuated Live Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Measles Attenuated Live Vaccine Sales by Region
6.1.1 APAC Measles Attenuated Live Vaccine Sales by Region (2018-2023)
6.1.2 APAC Measles Attenuated Live Vaccine Revenue by Region (2018-2023)
6.2 APAC Measles Attenuated Live Vaccine Sales by Type
6.3 APAC Measles Attenuated Live Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Measles Attenuated Live Vaccine by Country
7.1.1 Europe Measles Attenuated Live Vaccine Sales by Country (2018-2023)
7.1.2 Europe Measles Attenuated Live Vaccine Revenue by Country (2018-2023)
7.2 Europe Measles Attenuated Live Vaccine Sales by Type
7.3 Europe Measles Attenuated Live Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Measles Attenuated Live Vaccine by Country
8.1.1 Middle East & Africa Measles Attenuated Live Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Measles Attenuated Live Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Measles Attenuated Live Vaccine Sales by Type
8.3 Middle East & Africa Measles Attenuated Live Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine
10.3 Manufacturing Process Analysis of Measles Attenuated Live Vaccine
10.4 Industry Chain Structure of Measles Attenuated Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Measles Attenuated Live Vaccine Distributors
11.3 Measles Attenuated Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR MEASLES ATTENUATED LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Measles Attenuated Live Vaccine Market Size Forecast by Region
12.1.1 Global Measles Attenuated Live Vaccine Forecast by Region (2024-2029)
12.1.2 Global Measles Attenuated Live Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Measles Attenuated Live Vaccine Forecast by Type
12.7 Global Measles Attenuated Live Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.1.3 Merck Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.2.3 Pfizer Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.4.3 GSK Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi-Pasteur
13.5.1 Sanofi-Pasteur Company Information
13.5.2 Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.5.3 Sanofi-Pasteur Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi-Pasteur Main Business Overview
13.5.5 Sanofi-Pasteur Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.6.3 Novartis Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Bavarian Nordic
13.7.1 Bavarian Nordic Company Information
13.7.2 Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.7.3 Bavarian Nordic Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bavarian Nordic Main Business Overview
13.7.5 Bavarian Nordic Latest Developments
13.8 Medimmune
13.8.1 Medimmune Company Information
13.8.2 Medimmune Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.8.3 Medimmune Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Medimmune Main Business Overview
13.8.5 Medimmune Latest Developments
13.9 Changchun Keygen Biological Products
13.9.1 Changchun Keygen Biological Products Company Information
13.9.2 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.9.3 Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changchun Keygen Biological Products Main Business Overview
13.9.5 Changchun Keygen Biological Products Latest Developments
13.10 Shanghai Institute of Biological Products
13.10.1 Shanghai Institute of Biological Products Company Information
13.10.2 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.10.3 Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai Institute of Biological Products Main Business Overview
13.10.5 Shanghai Institute of Biological Products Latest Developments
13.11 Wuhan Institute of Biological Products
13.11.1 Wuhan Institute of Biological Products Company Information
13.11.2 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.11.3 Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Wuhan Institute of Biological Products Main Business Overview
13.11.5 Wuhan Institute of Biological Products Latest Developments
13.12 Lanzhou Institute of Biological Products
13.12.1 Lanzhou Institute of Biological Products Company Information
13.12.2 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
13.12.3 Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lanzhou Institute of Biological Products Main Business Overview
13.12.5 Lanzhou Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Measles Attenuated Live Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Measles Attenuated Live Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Measles Attenuated Live Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Measles Attenuated Live Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Measles Attenuated Live Vaccine Revenue by Application (2018-2023)
Table 13. Global Measles Attenuated Live Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Measles Attenuated Live Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Measles Attenuated Live Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Measles Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Measles Attenuated Live Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Measles Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Measles Attenuated Live Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Measles Attenuated Live Vaccine Producing Area Distribution and Sales Area
Table 21. Players Measles Attenuated Live Vaccine Products Offered
Table 22. Measles Attenuated Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Measles Attenuated Live Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Measles Attenuated Live Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Measles Attenuated Live Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Measles Attenuated Live Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Measles Attenuated Live Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Measles Attenuated Live Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Measles Attenuated Live Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Measles Attenuated Live Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Measles Attenuated Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Measles Attenuated Live Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Measles Attenuated Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Measles Attenuated Live Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Measles Attenuated Live Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Measles Attenuated Live Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Measles Attenuated Live Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Measles Attenuated Live Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Measles Attenuated Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Measles Attenuated Live Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Measles Attenuated Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Measles Attenuated Live Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Measles Attenuated Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Measles Attenuated Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Measles Attenuated Live Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Measles Attenuated Live Vaccine
Table 58. Key Market Challenges & Risks of Measles Attenuated Live Vaccine
Table 59. Key Industry Trends of Measles Attenuated Live Vaccine
Table 60. Measles Attenuated Live Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Measles Attenuated Live Vaccine Distributors List
Table 63. Measles Attenuated Live Vaccine Customer List
Table 64. Global Measles Attenuated Live Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Measles Attenuated Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Measles Attenuated Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Measles Attenuated Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Measles Attenuated Live Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Measles Attenuated Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Measles Attenuated Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Measles Attenuated Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Measles Attenuated Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Measles Attenuated Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Measles Attenuated Live Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Measles Attenuated Live Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Measles Attenuated Live Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Measles Attenuated Live Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 80. Merck Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Pfizer Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 85. Pfizer Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Serum Institute of India Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Serum Institute of India Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 90. Serum Institute of India Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Serum Institute of India Main Business
Table 92. Serum Institute of India Latest Developments
Table 93. GSK Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 95. GSK Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Sanofi-Pasteur Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 100. Sanofi-Pasteur Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi-Pasteur Main Business
Table 102. Sanofi-Pasteur Latest Developments
Table 103. Novartis Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 105. Novartis Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Bavarian Nordic Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 110. Bavarian Nordic Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bavarian Nordic Main Business
Table 112. Bavarian Nordic Latest Developments
Table 113. Medimmune Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Medimmune Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 115. Medimmune Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Medimmune Main Business
Table 117. Medimmune Latest Developments
Table 118. Changchun Keygen Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 120. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Changchun Keygen Biological Products Main Business
Table 122. Changchun Keygen Biological Products Latest Developments
Table 123. Shanghai Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 125. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Shanghai Institute of Biological Products Main Business
Table 127. Shanghai Institute of Biological Products Latest Developments
Table 128. Wuhan Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 130. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Wuhan Institute of Biological Products Main Business
Table 132. Wuhan Institute of Biological Products Latest Developments
Table 133. Lanzhou Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 135. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Lanzhou Institute of Biological Products Main Business
Table 137. Lanzhou Institute of Biological Products Latest Developments
Table 1. Measles Attenuated Live Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Measles Attenuated Live Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Measles Attenuated Live Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Measles Attenuated Live Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Measles Attenuated Live Vaccine Revenue by Application (2018-2023)
Table 13. Global Measles Attenuated Live Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Measles Attenuated Live Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Measles Attenuated Live Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Measles Attenuated Live Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Measles Attenuated Live Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Measles Attenuated Live Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Measles Attenuated Live Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Measles Attenuated Live Vaccine Producing Area Distribution and Sales Area
Table 21. Players Measles Attenuated Live Vaccine Products Offered
Table 22. Measles Attenuated Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Measles Attenuated Live Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Measles Attenuated Live Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Measles Attenuated Live Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Measles Attenuated Live Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Measles Attenuated Live Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Measles Attenuated Live Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Measles Attenuated Live Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Measles Attenuated Live Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Measles Attenuated Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Measles Attenuated Live Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Measles Attenuated Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Measles Attenuated Live Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Measles Attenuated Live Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Measles Attenuated Live Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Measles Attenuated Live Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Measles Attenuated Live Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Measles Attenuated Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Measles Attenuated Live Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Measles Attenuated Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Measles Attenuated Live Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Measles Attenuated Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Measles Attenuated Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Measles Attenuated Live Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Measles Attenuated Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Measles Attenuated Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Measles Attenuated Live Vaccine
Table 58. Key Market Challenges & Risks of Measles Attenuated Live Vaccine
Table 59. Key Industry Trends of Measles Attenuated Live Vaccine
Table 60. Measles Attenuated Live Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Measles Attenuated Live Vaccine Distributors List
Table 63. Measles Attenuated Live Vaccine Customer List
Table 64. Global Measles Attenuated Live Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Measles Attenuated Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Measles Attenuated Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Measles Attenuated Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Measles Attenuated Live Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Measles Attenuated Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Measles Attenuated Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Measles Attenuated Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Measles Attenuated Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Measles Attenuated Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Measles Attenuated Live Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Measles Attenuated Live Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Measles Attenuated Live Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Measles Attenuated Live Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 80. Merck Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Pfizer Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 85. Pfizer Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Serum Institute of India Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Serum Institute of India Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 90. Serum Institute of India Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Serum Institute of India Main Business
Table 92. Serum Institute of India Latest Developments
Table 93. GSK Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 95. GSK Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Sanofi-Pasteur Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi-Pasteur Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 100. Sanofi-Pasteur Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi-Pasteur Main Business
Table 102. Sanofi-Pasteur Latest Developments
Table 103. Novartis Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 105. Novartis Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Bavarian Nordic Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Bavarian Nordic Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 110. Bavarian Nordic Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bavarian Nordic Main Business
Table 112. Bavarian Nordic Latest Developments
Table 113. Medimmune Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Medimmune Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 115. Medimmune Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Medimmune Main Business
Table 117. Medimmune Latest Developments
Table 118. Changchun Keygen Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 120. Changchun Keygen Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Changchun Keygen Biological Products Main Business
Table 122. Changchun Keygen Biological Products Latest Developments
Table 123. Shanghai Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 125. Shanghai Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Shanghai Institute of Biological Products Main Business
Table 127. Shanghai Institute of Biological Products Latest Developments
Table 128. Wuhan Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 130. Wuhan Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Wuhan Institute of Biological Products Main Business
Table 132. Wuhan Institute of Biological Products Latest Developments
Table 133. Lanzhou Institute of Biological Products Basic Information, Measles Attenuated Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Product Portfolios and Specifications
Table 135. Lanzhou Institute of Biological Products Measles Attenuated Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Lanzhou Institute of Biological Products Main Business
Table 137. Lanzhou Institute of Biological Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of Measles Attenuated Live Vaccine
Figure 2. Measles Attenuated Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles Attenuated Live Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Measles Attenuated Live Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Measles Attenuated Live Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Liquid
Figure 11. Global Measles Attenuated Live Vaccine Sales Market Share by Type in 2022
Figure 12. Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Measles Attenuated Live Vaccine Consumed in Hospital
Figure 14. Global Measles Attenuated Live Vaccine Market: Hospital (2018-2023) & (K Units)
Figure 15. Measles Attenuated Live Vaccine Consumed in Clinic
Figure 16. Global Measles Attenuated Live Vaccine Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Measles Attenuated Live Vaccine Sales Market Share by Application (2022)
Figure 18. Global Measles Attenuated Live Vaccine Revenue Market Share by Application in 2022
Figure 19. Measles Attenuated Live Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Measles Attenuated Live Vaccine Sales Market Share by Company in 2022
Figure 21. Measles Attenuated Live Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Measles Attenuated Live Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Measles Attenuated Live Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Measles Attenuated Live Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Measles Attenuated Live Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Measles Attenuated Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Measles Attenuated Live Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Measles Attenuated Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Measles Attenuated Live Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Measles Attenuated Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Measles Attenuated Live Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Measles Attenuated Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Measles Attenuated Live Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Measles Attenuated Live Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Measles Attenuated Live Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Measles Attenuated Live Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Measles Attenuated Live Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Measles Attenuated Live Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Measles Attenuated Live Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Measles Attenuated Live Vaccine
Figure 72. Industry Chain Structure of Measles Attenuated Live Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Measles Attenuated Live Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Measles Attenuated Live Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Measles Attenuated Live Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Measles Attenuated Live Vaccine
Figure 2. Measles Attenuated Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles Attenuated Live Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Measles Attenuated Live Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Measles Attenuated Live Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Liquid
Figure 11. Global Measles Attenuated Live Vaccine Sales Market Share by Type in 2022
Figure 12. Global Measles Attenuated Live Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Measles Attenuated Live Vaccine Consumed in Hospital
Figure 14. Global Measles Attenuated Live Vaccine Market: Hospital (2018-2023) & (K Units)
Figure 15. Measles Attenuated Live Vaccine Consumed in Clinic
Figure 16. Global Measles Attenuated Live Vaccine Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Measles Attenuated Live Vaccine Sales Market Share by Application (2022)
Figure 18. Global Measles Attenuated Live Vaccine Revenue Market Share by Application in 2022
Figure 19. Measles Attenuated Live Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Measles Attenuated Live Vaccine Sales Market Share by Company in 2022
Figure 21. Measles Attenuated Live Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Measles Attenuated Live Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Measles Attenuated Live Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Measles Attenuated Live Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Measles Attenuated Live Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Measles Attenuated Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Measles Attenuated Live Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Measles Attenuated Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Measles Attenuated Live Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Measles Attenuated Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Measles Attenuated Live Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Measles Attenuated Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Measles Attenuated Live Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Measles Attenuated Live Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Measles Attenuated Live Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Measles Attenuated Live Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Measles Attenuated Live Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Measles Attenuated Live Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Measles Attenuated Live Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Measles Attenuated Live Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Measles Attenuated Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Measles Attenuated Live Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Measles Attenuated Live Vaccine
Figure 72. Industry Chain Structure of Measles Attenuated Live Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Measles Attenuated Live Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Measles Attenuated Live Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Measles Attenuated Live Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Measles Attenuated Live Vaccine Revenue Market Share Forecast by Application (2024-2029)
